The Alpha-1 Foundation is the world’s #1 funder of Alpha-1 research, including Alpha-1 related lung and liver disease.
Grants from the Alpha-1 Foundation support rigorous scientific research to advance Alpha-1 treatment and care and draw us closer to a cure. The Alpha-1 Foundation also funds research into ethical, legal, and social issues impacting people with genetic conditions.
2025 – 2026 In-Cycle Grants Award Program
The Alpha-1 Foundation Grants Award Program funds a wide range of meritorious research efforts designed to improve the health of individuals with AAT Deficiency with the ultimate goal of finding a cure.
The Foundation accepts and reviews Letter of Intent (LOI) submissions during the beginning of our annual grant cycle and selected LOIs are invited to submit a full proposal.
Travel Grants:
Up to $1,000
1. Objective: Support travel to attend national and international scientific conferences or meetings to present AAT-related abstracts or
2. Objective: Support cross-training at an established Alpha-1 laboratory by an established Alpha-1 investigator
1. 🎯 Direct Relevance to Alpha-1 Antitrypsin Deficiency
Successful projects focus on:
Molecular and genetic mechanisms of AATD
Novel therapeutics, gene therapy, or augmentation approaches
Disease modifiers for COPD, liver disease, or other AATD complications
Development of diagnostic tools and biomarkers
✅ Predictor: Research is explicitly tied to Alpha-1 pathophysiology, detection, or treatment.
2. 🧪 Strong Preliminary Data and Feasibility
Competitive applicants provide proof-of-concept studies or pilot data
Feasible aims within a 1–2 year grant period
Use of patient samples, animal models, or robust in vitro studies
✅ Predictor: Proposal demonstrates scientific rigor and clear deliverables.
3. 👩🔬 Focus on Early-Career Investigators
The Alpha-1 Foundation strongly supports:
Postdoctoral fellows and junior faculty
Early-stage researchers seeking pilot funding to generate data for NIH or other large grants
✅ Predictor: You’re an emerging scientist with strong mentorship support.
4. 🤝 Collaboration with Alpha-1 Networks
Use of Alpha-1 Foundation Research Registry, Clinical Resource Centers, or patient samples
Partnerships with clinicians, geneticists, and translational researchers
✅ Predictor: The proposal integrates with Alpha-1 Foundation infrastructure or collaborators.
5. 📢 Potential for Translational Impact
Preference for projects that bridge basic research to therapy or diagnostics
Focus on real-world applicability for patients
✅ Predictor: You clearly outline how results could improve care or lead to new treatments.
| Program | Amount | Audience | Purpose |
|---|---|---|---|
| Pilot and Feasibility Grants | $40,000–$75,000 | Early-career investigators | Generate preliminary data |
| Postdoctoral Fellowship | $40,000–$50,000 | Postdocs | 1–2 years of training |
| Research Grants | ~$100,000/year | Faculty | Mechanistic or translational studies |
| Bridge Grants | ~$50,000 | Investigators with near-miss NIH applications | Keep research funded temporarily |
🧬 Commonly Funded Topics
Gene therapy and gene editing for AATD
Augmentation therapy optimization
Understanding liver and lung disease progression
Newborn screening or early diagnostic tools
Alpha-1 biomarkers for clinical trials
📌 Tips for Strong Applications
✅ Emphasize how your work aligns with Alpha-1 priorities
✅ Include mentorship letters for early-career grants
✅ Plan for leveraging pilot data for NIH or industry funding
✅ Engage Alpha-1 patient registries or clinical networks
Alpha-1 Foundation provides grants to support travel to attend national and international scientific conferences or meetings to present AAT-related abstracts and to support cross-training at an established Alpha-1 laboratory by an established Alpha-1 investigator.
Sponsor Institute/Organizations: Alpha-1 Foundation
Sponsor Type: Corporate/Non-Profit
Address: 3300 Ponce de Leon Blvd. Coral Gables, Florida 33134
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 26, 2025
Sep 26, 2025
$1,000
Affiliation: Alpha-1 Foundation
Address: 3300 Ponce de Leon Blvd. Coral Gables, Florida 33134
Website URL: https://alpha1.org/grant-opportunities/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.